Pluristem Therapeutics Inc.

PSTI · NASDAQ
Analyze with AI
6/30/2025
6/30/2021
6/30/2020
6/30/2019
Operating Activities
Net Income-$23-$50-$29-$35
Dep. & Amort.$0$1$2$2
Deferred Tax$0$0$0$0
Stock-Based Comp.$2$14$3$5
Change in WC$0$4-$1-$1
Other Non-Cash$3-$0-$0-$0
Operating Cash Flow-$18-$31-$26-$29
Investing Activities
PP&E Inv.-$2-$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0-$30$0
Inv. Sales/Matur.$0$0$0$1
Other Inv. Act.$10-$7$0-$0
Investing Cash Flow$8-$7-$30$1
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$37$58$23
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$10$61$61$24
Financing Cash Flow$10$61$61$24
Forex Effect-$1-$1$0$0
Net Chg. in Cash-$0$23$4-$5
Supplemental Information
Beg. Cash$8$9$5$10
End Cash$7$32$9$5
Free Cash Flow-$20-$31-$27-$30